WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).

Civica Rx has teamed up with the U.S. government to aid in the COVID-19 response.

Americans are delaying critical stroke care as a result of the ongoing COVID-19 pandemic by not dialing 9-1-1 when they are experiencing a stroke.

As analyzed by the Kaiser Family Foundation, the outlook for job-based insurance under some post-COVID scenarios is unsurprisingly bleak.

A $3 trillion coronavirus relief bill proposed by House Democrats May 12 would allocate around $100 billion for hospitals and other healthcare providers to cover costs related to the public-health crisis.

Here’s a sampling of some of the best thinking on this body blow to the U.S. healthcare economy.